These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 4920933

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Clinical and biological study of an inhibitor of adrenocortical hormone synthesis: aminoglutethinide].
    Philbert M, Laudat MH, Laudat P, Bricaire H.
    Ann Endocrinol (Paris); 1968; 29(2):189-210. PubMed ID: 4298418
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Clinical experiences with aminoglutethimide (Elipten), a new inhibitor of steroid biosynthesis in the adrenal gland].
    Horký K, Küchel O, Gregorová I, Jiránková J, Matys Z.
    Schweiz Med Wochenschr; 1968 Nov 23; 98(47):1843-51. PubMed ID: 4236505
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of aminoglutethimide in a case of ectopic ACTH syndrome. Influence on steroid metabolism.
    McMillan M, Maisey MN.
    Acta Endocrinol (Copenh); 1970 Aug 23; 64(4):676-86. PubMed ID: 4318105
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Qualitative alterations in urinary 17-ketosteroid excretion during aminoglutethimide administration.
    Horký K, Küchel O, Gregorvá I, Stárka L.
    J Clin Endocrinol Metab; 1969 Feb 23; 29(2):297-9. PubMed ID: 4236926
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Fluctuating Cushing's syndrome, acute psychosis, aminoglutethimide therapy.
    Barnett IG, Nabarro JD, LeQuesne LP.
    Proc R Soc Med; 1970 Apr 23; 63(4):338-9. PubMed ID: 5441960
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Inhibition of adrenocortical steroid production in therapy].
    Bricaire H, Philbert M, Luton JP.
    Rev Fr Etud Clin Biol; 1968 Apr 23; 13(6):563-7. PubMed ID: 4178146
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Aminoglutethimide (Elipten-Ciba) as an inhibitor of adrenal steroidogenesis: mechanism of action and therapeutic trial.
    Cash R, Brough AJ, Cohen MN, Satoh PS.
    J Clin Endocrinol Metab; 1967 Sep 23; 27(9):1239-48. PubMed ID: 4292247
    [No Abstract] [Full Text] [Related]

  • 17. The treatment of congenital adrenal hyperplasia with aminoglutethimide.
    Hamilton W, Moodie T.
    Dev Med Child Neurol; 1970 Oct 23; 12(5):618-28. PubMed ID: 5477945
    [No Abstract] [Full Text] [Related]

  • 18. Effects of O,p'DDD and aminoglutethimide on metastatic adrenocortical carcinoma.
    Bochner F, Lloyd HM, Roeser HP, Thomas MJ.
    Med J Aust; 1969 Apr 19; 1(16):809-12. PubMed ID: 5769733
    [No Abstract] [Full Text] [Related]

  • 19. Effects of aminoglutethimide on the prostate glands of rats--a preliminary study.
    Morales A, Connolly JG, Mobbs BG, Kraus A.
    Can J Surg; 1971 Mar 19; 14(2):154-60. PubMed ID: 5554009
    [No Abstract] [Full Text] [Related]

  • 20. Suppression of tumorous adrenal hyperfunction by aminoglutethimide.
    Smilo RP, Earll JM, Forsham PH.
    Metabolism; 1967 Apr 19; 16(4):374-7. PubMed ID: 4290376
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.